4.2 Article

An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome

Journal

PEDIATRIC RHEUMATOLOGY
Volume 17, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12969-019-0328-3

Keywords

Macrophage activation syndrome; Juvenile idiopathic arthritis; Interferons; Interleukins; Chemokines

Funding

  1. Hoffmann-La Roche
  2. Novimmune
  3. Novartis
  4. Abbvie
  5. SOBI

Ask authors/readers for more resources

BackgroundSystemic juvenile idiopathic arthritis (sJIA) is an inflammatory condition that presents with fever, rash and arthritis. At onset systemic features are predominant and the diagnosis may be a challenge. Secondary hemophagocytic lymphohistiocytosis (sHLH) forms may be associated with different disorders, including rheumatic diseases, and this form is called macrophage activation syndrome (MAS). CXCL9 levels, a chemokine induced by IFN, are significantly elevated in patients with sHLH or MAS and are correlated with laboratory features of disease activity. High levels of IL-18 have been reported in patients with MAS during sJIA, as well as in some patients with sHLH and IL-18 is indeed known to induce IFN production.FindingsWe report a patient with a clinical presentation highly suggestive for systemic juvenile idiopathic arthritis (sJIA) onset complicated by MAS, and was later diagnosed with purine nucleoside phosphorylase (PNP)-deficiency with HLH. Some unusual features appeared when HLH was controlled and further investigations provided the correct diagnosis. Serum CXCL9 and IL-18 levels were found markedly elevated at disease onset, during the active phase of MAS and decreased progressively during the course.ConclusionThe reported case underlines the potential difficulties in discriminating sJIA from other causes of systemic inflammation. Furthermore, this supports the notion that especially in young children with a sJIA-like disease other mimicking conditions should be actively sought for. CXCL9 and IL-18 levels suggested that patients with PNP-deficiency may have a subclinical activation of the IFN pathway and indeed they are predisposed to develop sHLH.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

IgM on the surface of T cells: a novel biomarker of pediatric-onset systemic lupus erythematosus

Manuela Colucci, Barbara Ruggiero, Alessandra Gianviti, Maria Manuela Rosado, Rita Carsetti, Claudia Bracaglia, Fabrizio De Benedetti, Francesco Emma, Marina Vivarelli

Summary: The presence of IgM on T cells can effectively distinguish between pediatric patients with SLE and FHN, with T cell IgM positivity showing high sensitivity and specificity for the diagnosis of SLE.

PEDIATRIC NEPHROLOGY (2021)

Article Allergy

Mutations at the C-terminus of CDC42 cause distinct hematopoietic and autoinflammatory disorders

Simona Coppola, Antonella Insalaco, Erika Zara, Martina Di Rocco, Denise Pires Marafon, Francesca Spadaro, Luca Pannone, Luciapia Farina, Luca Pasquini, Simone Martinelli, Fabrizio De Benedetti, Marco Tartaglia

Summary: This study clinically and functionally classified three pathogenic variants of CDC42 at the C-terminus and found that they differently impact protein stability, localization, and function, causing various clinical diseases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Rheumatology

The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort

Marta Bustaffa, Isabelle Kone-Paut, Seza Ozen, Gayane Amaryan, Efimia Papadopoulou-Alataki, Romina Gallizzi, Maria Carrabba, Yonatan Butbul Aviel, Luca Cantarini, Maria Alessio, Jordi Anton, Laura Obici, Faysal Gok, Ezgi Deniz Batu, Estefania Moreno, Paul Brogan, Maria Trachana, Gabriele Simonini, Donato Rigante, Yosef Uziel, Antonella Insalaco, Maria Cristina Maggio, Nicolino Ruperto, Marco Gattorno, L. Rossi Semerano

Summary: The new EPCC and INSAID classification of MEFV variants can identify two distinct groups of FMF patients, which differ in clinical characteristics, therapeutic approach, and response to treatment.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)

Article Immunology

Identification of a Novel Mutation in TNFAIP3 in a Family With Poly-Autoimmunity

Marianna Nicoletta Rossi, Silvia Federici, Andrea Uva, Chiara Passarelli, Camilla Celani, Ivan Caiello, Valentina Matteo, Stefano Petrocchi, Eva Piano Mortari, Fabrizio De Benedetti, Giusi Prencipe, Antonella Insalaco

Summary: A20 gene mutations are associated with the development of HA20, an autoimmune disease, and functional analysis confirmed the pathogenicity of the mutations. The study demonstrated the role of A20 not only in regulating the NF-kB pathway, but also the IFN gamma pathway.

FRONTIERS IN IMMUNOLOGY (2022)

Article Hematology

Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH

Arianna De Matteis, Manuela Colucci, Marianna N. Rossi, Ivan Caiello, Pietro Merli, Nicola Tumino, Valentina Bertaina, Manuela Pardeo, Claudia Bracaglia, Franco Locatelli, Fabrizio De Benedetti, Giusi Prencipe

Summary: The activation profile of CD8(+) T cells can distinguish different types of HLH patients and those with early sepsis. The frequency of CD4(dim)CD8(+) T cells is correlated with the severity of MAS.

BLOOD (2022)

Article Immunology

Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis

Luciapia Farina, Gaetana Minnone, Stefano Alivernini, Ivan Caiello, Lucy MacDonald, Marzia Soligo, Luigi Manni, Barbara Tolusso, Simona Coppola, Erika Zara, Libenzio Adrian Conti, Angela Aquilani, Silvia Magni-Manzoni, Mariola Kurowska-Stolarska, Elisa Gremese, Fabrizio De Benedetti, Luisa Bracci-Laudiero

Summary: The study shows that the activation of the p75NTR/proNGF axis promotes pro-inflammatory responses in synovial fibroblasts, contributing to chronic synovial inflammation. Inhibiting the p75NTR receptor may be a novel therapeutic approach for chronic arthritis.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

Development and implementation of the AIDA International Registry for patients with Behcet's disease

Antonio Vitale, Francesca Della Casa, Gaafar Ragab, Ibrahim A. Almaghlouth, Giuseppe Lopalco, Rosa Maria Pereira, Silvana Guerriero, Marcello Govoni, Petros P. Sfikakis, Roberto Giacomelli, Francesco Ciccia, Sara Monti, Piero Ruscitti, Matteo Piga, Claudia Lomater, Abdurrahman Tufan, Daniela Opris-Belinski, Giacomo Emmi, Jose Hernandez-Rodriguez, Burak Karkas, Gian Domenico Sebastiani, Elena Bartoloni, Nurullah Akkoc, Marco Cattalini, Giovanni Conti, Gulen Hatemi, Armin Maier, Paola Parronchi, Emanuela Del Giudice, Sukran Erten, Antonella Insalaco, Francesca Li Gobbi, Maria Cristina Maggio, Farhad Shahram, Valeria Caggiano, Mohamed Tharwat Hegazy, Kazi Nur Asfina, Maria Morrone, Leandro L. Prado, Rosanna Dammacco, Francesca Ruffilli, Aikaterini Arida, Luca Navarini, Ilenia Pantano, Lorenzo Cavagna, Alessandro Conforti, Alberto Cauli, Elena Maria Marucco, Hamit Kucuk, Ruxandra Ionescu, Irene Mattioli, Gerard Espinosa, Olga Araujo, Claudia Canofari, Jurgen Sota, Ahmed Hatem Laymouna, Asma A. Bedaiwi, Sergio Colella, Henrique Ayres M. Giardini, Valeria Albano, Andrea Lo Monaco, George E. Fragoulis, Riza Can Kardas, Virginia Berlengiero, Mohamed A. Hussein, Francesca Ricci, Francesco La Torre, Donato Rigante, Ewa Wiesik-Szewczyk, Micol Frassi, Stefano Gentileschi, Gian Marco Tosi, Marilia Ambiel Dagostin, Ayman Abdel-Monem Ahmed Mahmoud, Maria Tarsia, Giovanni Alessio, Rolando Cimaz, Teresa Giani, Carla Gaggiano, Florenzo Iannone, Paola Cipriani, Mariam Mourabi, Veronica Spedicato, Sara Barneschi, Emma Aragona, Alberto Balistreri, Bruno Frediani, Claudia Fabiani, Luca Cantarini

Summary: The purpose of this paper is to discuss the design, development, and implementation of the AutoInflammatory Disease Alliance (AIDA) International Registry for Behcet's disease (BD) patients. The registry aims to collect standardized real-life data from pediatric and adult patients, using the Research Electronic Data Capture (REDCap) tool. As of February 7th, 2022, 110 centers from 23 countries have participated, with 54 centers obtaining approval from their local Ethics Committees. The registry collects a wide range of data, including demographics, clinical manifestations, therapies, and healthcare access.

INTERNAL AND EMERGENCY MEDICINE (2022)

Article Medicine, General & Internal

Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome

Antonio Vitale, Valeria Caggiano, Francesca Della Casa, Jose Hernandez-Rodriguez, Micol Frassi, Sara Monti, Abdurrahman Tufan, Salvatore Telesca, Edoardo Conticini, Gaafar Ragab, Giuseppe Lopalco, Ibrahim Almaghlouth, Rosa Maria R. Pereira, Derya Yildirim, Marco Cattalini, Achille Marino, Teresa Giani, Francesco La Torre, Piero Ruscitti, Emma Aragona, Ewa Wiesik-Szewczyk, Emanuela Del Giudice, Petros P. Sfikakis, Marcello Govoni, Giacomo Emmi, Maria Cristina Maggio, Roberto Giacomelli, Francesco Ciccia, Giovanni Conti, Djouher Ait-Idir, Claudia Lomater, Vito Sabato, Matteo Piga, Ali Sahin, Daniela Opris-Belinski, Ruxandra Ionescu, Elena Bartoloni, Franco Franceschini, Paola Parronchi, Amato de Paulis, Gerard Espinosa, Armin Maier, Gian Domenico Sebastiani, Antonella Insalaco, Farhad Shahram, Paolo Sfriso, Francesca Minoia, Maria Alessio, Joanna Makowska, Gulen Hatemi, Nurullah Akkoc, Francesca Li Gobbi, Antonio Gidaro, Alma Nunzia Olivieri, Sulaiman M. Al-Mayouf, Sukran Erten, Stefano Gentileschi, Ibrahim Vasi, Maria Tarsia, Ayman Abdel-Monem Ahmed Mahmoud, Bruno Frediani, Musa Fares Alzahrani, Ahmed Hatem Laymouna, Francesca Ricci, Fabio Cardinale, Karina Jahnz-Rozyk, Gian Marco Tosi, Francesca Crisafulli, Alberto Balistreri, Marilia A. Dagostin, Mahmoud Ghanema, Carla Gaggiano, Jurgen Sota, Ilenia Di Cola, Claudia Fabiani, Henrique A. Mayrink Giardini, Alessandra Renieri, Alessandra Fabbiani, Anna Carrer, Monica Bocchia, Federico Caroni, Donato Rigante, Luca Cantarini

Summary: This paper presents an international registry for VEXAS syndrome, designed to collect real-life data and provide real-world evidence for daily clinical practice, potentially enhancing international collaboration and data sharing.

FRONTIERS IN MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis

Antonio Brucato, Alistair Wheeler, Sushil Allen Luis, Antonio Abbate, Paul C. Cremer, Liangxing Zou, Antonella Insalaco, Martin Lewinter, Basil S. Lewis, David Lin, Stephen Nicholls, Massimo Pancrazi, Allan L. Klein, Massimo Imazio, John F. Paolini

Summary: This study suggests that rapid discontinuation of oral therapies for recurrent pericarditis while transitioning to rilonacept monohterapy is feasible without triggering recurrence.

HEART (2023)

Article Medicine, General & Internal

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases

Carla Gaggiano, Antonio Vitale, Abdurrahman Tufan, Gaafar Ragab, Emma Aragona, Ewa Wiesik-Szewczyk, Djouher Ait-Idir, Giovanni Conti, Ludovica Iezzi, Maria Cristina Maggio, Marco Cattalini, Francesco La Torre, Giuseppe Lopalco, Elena Verrecchia, Amato de Paulis, Ali Sahin, Antonella Insalaco, Petros P. Sfikakis, Achille Marino, Micol Frassi, Benson Ogunjimi, Daniela Opris-Belinski, Paola Parronchi, Giacomo Emmi, Farhad Shahram, Francesco Ciccia, Matteo Piga, Jose Hernandez-Rodriguez, Rosa Maria R. Pereira, Maria Alessio, Roberta Naddei, Alma Nunzia Olivieri, Emanuela Del Giudice, Paolo Sfriso, Piero Ruscitti, Francesca Li Gobbi, Hamit Kucuk, Jurgen Sota, Mohamed A. Hussein, Giuseppe Malizia, Karina Jahnz-Rozyk, Rawda Sari-Hamidou, Mery Romeo, Francesca Ricci, Fabio Cardinale, Florenzo Iannone, Francesca Della Casa, Marco Francesco Natale, Katerina Laskari, Teresa Giani, Franco Franceschini, Vito Sabato, Derya Yildirim, Valeria Caggiano, Mohamed Tharwat Hegazy, Rosalba Di Marzo, Aleksandra Kucharczyk, Ghalia Khellaf, Maria Tarsia, Ibrahim A. Almaghlouth, Ahmed Hatem Laymouna, Violetta Mastrorilli, Laura Dotta, Luca Benacquista, Salvatore Grosso, Francesca Crisafulli, Veronica Parretti, Heitor F. Giordano, Ayman Abdel-Monem Ahmed Mahmoud, Rossana Nuzzolese, Marta De Musso, Cecilia Beatrice Chighizola, Stefano Gentileschi, Mirella Morrone, Ilenia Di Cola, Veronica Spedicato, Henrique A. Mayrink Giardini, Ibrahim Vasi, Alessandra Renieri, Alessandra Fabbiani, Maria Antonietta Mencarelli, Bruno Frediani, Alberto Balistreri, Gian Marco Tosi, Claudia Fabiani, Merav Lidar, Donato Rigante, Luca Cantarini

Summary: This article describes an international, electronic-based registry platform for mAIDs patients, which aims to collect and share data for research and improve patient management.

FRONTIERS IN MEDICINE (2022)

Article Rheumatology

Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant

Brian Skaug, Xinjian Guo, Yuanteng Jeff Li, Julio Charles, Kay T. Pham, Jacob Couturier, Dorothy E. Lewis, Claudia Bracaglia, Ivan Caiello, Maureen D. Mayes, Shervin Assassi

Summary: The R206C polymorphism in the coding region of DNASE1L3 gene impairs its ability to digest extracellular DNA, leading to reduced digestion of circulating DNA in plasma from SSc patients.

RHEUMATOLOGY (2023)

Article Rheumatology

Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III Trial

Marco Gattorno, Laura Obici, Inmaculada Calvo Penades, Tilmann Kallinich, Susanne Benseler, Elise Dekker, Jeremy Levy, Fabrizio De Benedetti, Helen Lachmann

Summary: This study assessed the efficacy, safety, and tolerability of canakinumab in TRAPS patients during a 72-week long-term, open-label extension. The results showed that long-term canakinumab treatment effectively controlled disease activity and reduced flare incidence in TRAPS patients. No new safety concerns were identified.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Efficacy and safety of emapalumab in macrophage activation syndrome

Fabrizio De Benedetti, Alexei A. Grom, Paul A. Brogan, Claudia Bracaglia, Manuela Pardeo, Giulia Marucci, Despina Eleftheriou, Charalampia Papadopoulou, Grant S. Schulert, Pierre Quartier, Jordi Anton, Christian Laveille, Rikke Frederiksen, Veronica Asnaghi, Maria Ballabio, Philippe Jacqmin, Cristina de Min

Summary: The objective of this study was to confirm the adequacy of an emapalumab dosing regimen in relation to interferon-γ (IFN-γ) activity and assess its efficacy and safety in treating MAS secondary to sJIA or AOSD. The results showed that emapalumab was efficacious in inducing remission of MAS and viral infections were observed.

ANNALS OF THE RHEUMATIC DISEASES (2023)

No Data Available